Advances in the proteomic discovery of novel therapeutic targets in cancer. - Wikidata - awgldk - TriplyDB

Advances in the proteomic discovery of novel therapeutic targets in cancer.

Advances in the proteomic discovery of novel therapeutic targets in cancer.

http://www.wikidata.org/entity/Q37260569

about

Reverse phase protein arrays in signaling pathways: a data integration perspective The systemic nature of CKD.Progress of clinical research on targeted therapy combined with thoracic radiotherapy for non-small-cell lung cancer Proteome research in urothelial carcinoma.BMI and lymph node ratio may predict clinical outcomes of gastric cancer.Phosphoglycerate Mutase 1 Predicts the Poor Prognosis of Oral Squamous Cell Carcinoma and is Associated with Cell Migration.Combining bioinformatics and MS-based proteomics: clinical implications.The implementation of omics technologies in cancer microbiome research

P2860

Q26799716-1F47D9EA-0075-4683-B233-802363147E8D Q30234695-165F5D50-95C1-4B43-886F-0C0F82BE05FB Q33720025-E0FAD8A0-83A4-4E85-8963-94FADD0928F4 Q38461516-2A0EC088-15E0-4C89-9ACA-FA75F6A9A2F5 Q39257645-F8860D77-E8A7-4566-BD31-16308095B33F Q41439794-10CCC0E0-3F55-43C1-BE91-545720BDEE10 Q42653805-3BDFD7B3-6A42-47A5-9118-C1704208E155 Q58762649-3A7D66BB-96B3-4007-870C-F08DDAEC7E27

P2860

Advances in the proteomic discovery of novel therapeutic targets in cancer.

http://www.wikidata.org/entity/Q37260569

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 24 October 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Advances in the proteomic discovery of novel therapeutic targets in cancer.

@en

Advances in the proteomic discovery of novel therapeutic targets in cancer.

@nl

type

label

Advances in the proteomic discovery of novel therapeutic targets in cancer.

@en

Advances in the proteomic discovery of novel therapeutic targets in cancer.

@nl

prefLabel

Advances in the proteomic discovery of novel therapeutic targets in cancer.

@en

Advances in the proteomic discovery of novel therapeutic targets in cancer.

@nl

P1433

Q37260569-E44404D1-BDB6-48E5-921E-5A25986139D1

P1476

Q37260569-0974EE3F-E4E0-4658-B335-78B40F1C20A4

P2093

Q37260569-6090C256-B0D1-4542-8482-7C6FA48F85A3

Q37260569-C32D08F6-D533-4817-8EB5-C1257BED6979

Q37260569-CA11CA2B-6A07-4464-8A33-9E9623165914

P275

Q37260569-8FB824ED-B880-47FC-8C87-2E9D64DDBB04

P2860

Q37260569-003F32A8-D0B6-457B-BD75-29458B52BF86

Q37260569-06FEED4E-5150-4D5C-A0D0-B1DCD5D2E438

Q37260569-07B4B1D8-3F77-4CAE-9D49-33EDBE5509C1

Q37260569-090B079D-0ECA-4548-A493-69175BD0B9FB

Q37260569-090BC7F4-5B9F-4C72-9809-188D2D9E2B82

Q37260569-0B0FAC35-4322-4BC8-B06B-BCB3169F7114

Q37260569-0CE0FEB8-FAC8-473B-81B0-DD6F08854867

Q37260569-0ED133E0-BCF8-40A1-8E9A-12302B692759

Q37260569-0F6DEBD1-D7BB-40D6-A5F7-26512F3F0D94

Q37260569-11CBD913-D261-4F6D-A439-5844DF42C0C3

P304

Q37260569-45B80F76-8181-484A-9F20-0CC15A87727F

P31

Q37260569-0EE82CCE-6B88-4079-8F78-A0BA449347CE

Q37260569-D5463D09-ADAA-48A5-927E-59F136C0BFA7

P356

Q37260569-7A118097-D85D-42C2-A1CF-500BC16FBD78

P407

Q37260569-CFA65371-FD68-4A18-ABF6-3EE2B9FE31F4

P478

Q37260569-01713D2E-E7D2-4E0B-A6FE-CE74C643E9CE

P5008

Q37260569-EDCE8D1D-C92A-4168-A112-DFAD3AC5B664

P577

Q37260569-5CED17C9-F2E1-4552-80A2-316ABE396DEC

P698

Q37260569-1ED0FB09-591C-4BF9-96B6-51DC5F9DDA7F

P921

Q37260569-5A799440-AC87-4596-8016-B8533F79E5E3

P932

Q37260569-FDB85E8E-9DD3-4B55-A269-0258AE09B81F

P356

P1433

Drug Design, Development and Therapy

P1476

Advances in the proteomic discovery of novel therapeutic targets in cancer.

@en

P2093

Guangdi Wang

http://www.w3.org/2001/XMLSchema#string

Jin Zou

http://www.w3.org/2001/XMLSchema#string

Shanchun Guo

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

Identification of small molecule inhibitors of pyruvate kinase M2

Protein kinase D1 regulates cofilin-mediated F-actin reorganization and cell motility through slingshot

Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling

Integrative genomic and proteomic analyses identify targets for Lkb1-deficient metastatic lung tumors

Mass spectrometry-based proteomics in preclinical drug discovery

Structural basis for the interaction between tankyrase-2 and a potent Wnt-signaling inhibitor

Nonsteroidal anti-inflammatory agents differ in their ability to suppress NF-kappaB activation, inhibition of expression of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell proliferation

Quantitative mass spectrometry in proteomics: a critical review

Phosphoproteomics identified Endofin, DCBLD2, and KIAA0582 as novel tyrosine phosphorylation targets of EGF signaling and Iressa in human cancer cells

Mitochondrial respiration--an important therapeutic target in melanoma

P304

1259-1271

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/DDDT.S52216

http://www.w3.org/2001/XMLSchema#string

P407

P478

7

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2013-10-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24187485

http://www.w3.org/2001/XMLSchema#string

P921

P932

3810204

http://www.w3.org/2001/XMLSchema#string